Summary
Reata Pharmaceuticals Inc
Founded in 2002
Description
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondri...
Strengths
- Reata Pharmaceuticals Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Reata Pharmaceuticals Inc was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Reata Pharmaceuticals Inc's annual revenue
$2216000
Based on Kona Equity data
-
Revenue per employee
$6903
-
Variance of revenue growth
0.55
-
Annual revenue growth since founding
$100727
-
Revenue growth rate from first known quarter to current
100.0%
Employee Count
321 employees
-
Employee growth rate from first known quarter to current
91.7%
Executives
David Chapman
Vice President, Marketing
d**@reatapharma.comOscar Sanchez
Vice President, Quality
o**@reatapharma.comEvan Dionne
Clinincal Trial Associate
e**@reatapharma.comAlex Gold
Head Vice President, Clinical Development
a**@reatapharma.comDebra Asner
Senior Clinical Data Analyst & Chief People Officer
d**@reatapharma.comMichael Wortley
Chief Legal Officer & Executive Vice President
m**@reatapharma.comJerry Thompson
Assistant VP, Tax & Treasury
j**@reatapharma.comCraig Bates
Senior Director, Process Chemistry
c**@reatapharma.comAmee Martinez
Quality Assurance Associate
a**@reatapharma.comSmita Bulchandani
Senior Manager, Submissions Management
s**@reatapharma.comSeemi Khan
Chief Medical Officer & Senior VP
s**@reatapharma.comManmeet Soni
Executive VP & Chief Financial Officer & Chief Operating Officer
m**@reatapharma.comColin Meyer
Executive VP & Chief Research & Development Officer
c**@reatapharma.comSteve Harman
Chief Human Resources Officer
s**@reatapharma.comAndrea Loewen
Vice President, Global Regulatory Affairs
a**@reatapharma.comAmy Bambic
Director, Risk Management
a**@reatapharma.comWarren Huff
CEO
w**@reatapharma.comTaylor Arnold
Financial Analyst
t**@reatapharma.comMelanie Chin
Manager, Product Development
m**@reatapharma.comColeenique Jefferson
Clinical Program Operations Project Lead
c**@reatapharma.comDawn Bir
Chief Commercial Officer & Executive Vice President
d**@reatapharma.comRajvanti Ahir
Quality Assurance Associate
r**@reatapharma.comRobin Kral
Intellectual Property Vice President, Licensing
r**@reatapharma.comBryant Gay
Associate Director, Process Chemistry
b**@reatapharma.comSerge Fadjoh
Associate Director, Clinical Quality Assurance, Pharmacovigilance
s**@reatapharma.comVincent Badalamenti
Assistant Vice President Pharmacovigilance
v**@reatapharma.comMatthew Mckee
Clinical Trial Associate
m**@reatapharma.comAngie Goldsberry
Associate VP, Product Development
a**@reatapharma.comMark Comparably
CEO at Celgene
m**@reatapharma.comChristian Wigley
Vice President
c**@reatapharma.comTodd Smith
Associate VP, Project Management
t**@reatapharma.comDeborah Ferguson
Assistant VP, Research Strategy & Scientific Communications
d**@reatapharma.comGiovanni Caforio
CEO at Bristol-Myers Squibb
g**@reatapharma.comGiovanni _Ngcontent-Sc84=
CEO at Bristol-Myers Squibb
g**@reatapharma.comVinny Jindal
Vice President, Strategy
v**@reatapharma.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.94 M
-
Page views per visitor
2.0
-
Daily time
1:23
-
Bounce Rate
112.0 %
Location
Unlock unlimited leads
Key Information
- Name: Reata Pharmaceuticals Inc
- Category: Pharmaceuticals
- Industry: Pharmaceutical Company
- SIC: 87; 873
- NAICS: 32541; 42421
See similar companies
-
By City Plano Small Pharmaceutical Company in Plano Mid-size Pharmaceutical Company in Plano Pharmaceuticals in Plano Small Pharmaceuticals in Plano Mid-size Pharmaceuticals in Plano
-
By State TX Small companies in TX Pharmaceuticals in TX Small Pharmaceuticals in TX Mid-size Pharmaceuticals in TX Small Pharmaceutical Company in TX Mid-size Pharmaceutical Company in TX
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Pharmaceuticals and Pharmaceutical Company
-
Firmographic data G Score of 6 Founded in 2002 SIC: 87 SIC: 873 NAICS: 32541 NAICS: 42421 #Business Services General #Business Services #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Reata Pharmaceuticals Inc's headquarters are located at 5320 Legacy Drive Plano, TX 75024.
Reata Pharmaceuticals Inc's official website is reatapharma.com
Reata Pharmaceuticals Inc's annual revenue is $2.2 M.
Reata Pharmaceuticals Inc's SIC: 87; 873
Reata Pharmaceuticals Inc's NAICS: 32541; 42421.
Reata Pharmaceuticals Inc has 321 employees
Reata Pharmaceuticals Inc is in the industry of Pharmaceuticals.
